.svg){kind=small}
Jun-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Generic AF has shown a consistent performance in the Edible category in New York. Starting at rank 16 in March 2024, the brand saw a slight dip to rank 17 in April, but quickly recovered to rank 13 by May and maintained this position into June. This upward trend is indicative of the brand's growing popularity and market penetration in the state. The steady increase in sales from $64,802 in March to $84,071 in May, followed by a slight dip to $79,530 in June, suggests that while there may be some fluctuations, the overall trajectory remains positive.
However, it's important to note that Generic AF did not make it into the top 30 brands in other states or categories during this period, which could be seen as a point of concern. This lack of presence outside of New York's Edible category highlights potential areas for improvement and expansion. For a brand looking to establish a broader footprint, understanding the dynamics in other states and categories will be crucial for future growth. The performance in New York serves as a strong foundation, but diversification will be key to sustaining long-term success.
Competitive Landscape
In the competitive landscape of the New York edible cannabis market, Generic AF has shown a notable improvement in its ranking and sales over the past few months. Starting from a rank of 16 in March 2024, Generic AF climbed to 13 by May and maintained this position in June, indicating a positive trend in consumer preference. This upward movement is significant when compared to competitors like 1906, which fluctuated between ranks 14 and 18, and Tyson 2.0, which saw a dramatic rise from 28 in March to 12 in April but then settled at 15 in June. Meanwhile, Jaunty consistently outperformed Generic AF, holding steady within the top 11 ranks. Another competitor, Foy, made a significant leap from rank 23 in March to 12 in June, surpassing Generic AF. These dynamics suggest that while Generic AF is gaining traction, it faces stiff competition from both established and emerging brands, highlighting the importance of strategic marketing and product differentiation to sustain and enhance its market position.
Notable Products
In June 2024, the top-performing product for Generic AF was Peach Gummies 20-Pack (100mg), which climbed from the 4th position in May to the 1st position with sales reaching 868 units. Strawberry Gummies 20-Pack (100mg), previously holding the top spot, fell to 2nd place with sales of 765 units. Blood Orange Gummies 20-Pack (100mg) maintained its consistent ranking, moving from 2nd place in May to 3rd in June, recording 667 units sold. Green Apple Gummies 20-Pack (100mg) remained steady at the 4th position, while Cherry Gummies 20-Pack (100mg) dropped from 3rd to 5th place. Overall, the shifts in rankings highlight Peach Gummies' significant rise in popularity and sales performance.
Top Selling Cannabis Brands
